Skip to content

Effect Of Extracorporeal Shockwave Therapy on Tension-Type Headache in Adolescent Females

Effect Of Extracorporeal Shockwave Therapy on Tension-Type Headache in Adolescent Females

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06482736
Enrollment
40
Registered
2024-07-01
Start date
2023-01-05
Completion date
2024-01-22
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tension-Type Headache

Brief summary

Chronic headaches in adolescents can have consequences such as absence from school, inability to maintain social activities, and additional disorders such as anxiety, depression, problems sleeping, and reduced quality of life to investigates the efficacy shock wave diathermy on tension headaches in adolescent females

Detailed description

The prevalence of headaches increases with age, with a prevalence of 82% during adolescence. Extracorporeal Shockwave Therapy could reduce the pain of myofascial pain syndrome by pain signal alteration, promoting angiogenesis and increasing perfusion in ischemic tissues induced by sensitization of nociceptors and muscle ischemia

Interventions

DEVICEExtracorporeal Shockwave Therapy

Extracorporeal Shockwave Therapy could reduce the pain of myofascial pain syndrome by pain signal alteration, promoting angiogenesis and increasing perfusion in ischemic tissues induced by sensitization of nociceptors and muscle ischemia.

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Suffering from chronic tension headache (headaches occur 15 or more days a month for at least three months). * Their age will range from 15 to 18 years. * Having a sedentary lifestyle (A weekly physical activity of \< 600 MET-minutes/ week in the international physical activity questionnaire) * Having regular menstruation (28 to 34 days).

Exclusion criteria

* Using oral contraceptives or * any hormonal treatment in the previous six months.

Design outcomes

Primary

MeasureTime frameDescription
digital algometerThe evaluation took place before and after 8 treatment visits using the positional inhibition technique. The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.Measure pain intensity pre and post treatment which tested the pain points of the muscles: upper trapezius, levator scapula, sternocleidomastoid, splenius head and neck bilaterally.
Electromyography (EMG) for neck musclesThe evaluation took place before and after 8 treatment visits using the positional inhibition technique. The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.Measure muscle activity pre and post treatmentupper trapezius, levator scapula, sternocleidomastoid, splenius head and neck bilaterally
Headache impact test questionnaireThe treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.The evaluation took place before and after 8 treatment visits using the positional inhibition technique. The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026